Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 4/2023

08-02-2023 | Mood Disorders | INTEGRATIVE CARE (M FRENKEL, SECTION EDITOR)

Recent Progress in Mind–Body Therapies in Cancer Care

Authors: Julie M. Deleemans, Haley Mather, Athina Spiropoulos, Kirsti Toivonen, Mohamad Baydoun, Linda E. Carlson

Published in: Current Oncology Reports | Issue 4/2023

Login to get access

Abstract

Purpose of Review

Mind–body therapies (MBTs) are integrative medicine modalities that continue to grow in popularity among people with cancer. MBTs are used to enhance well-being and most commonly include relaxation and imagery, hypnosis, yoga, meditation, Tai Chi and Qigong, and creative therapies. Biofield and psychedelic-assisted therapies are also gaining momentum as MBTs. Herein, recent literature was narratively reviewed to summarize the effectiveness of these MBTs within the context of cancer care.

Recent Findings

There is growing evidence for the effectiveness of MBTs for addressing a myriad of physical (e.g., pain) and psychosocial (e.g., depression, fatigue) symptoms and biomarkers of stress and immune function in people with cancer. Psychedelic-assisted therapies have robust, sustained effects on symptoms of depression, anxiety, and distress in small clinical trials to date. However, across modalities, MBT studies continue to struggle with methodological issues such as intervention standardization, facilitator training, small sample sizes, and short follow-up.

Summary

Accumulating evidence supports the use of MBTs for people with cancer. Future research should work to address methodological issues and focus on creating knowledge translation tools; these can be leveraged to better educate health care providers and patients regarding evidence-based MBT options to support patients in making informed decisions about their health.
Literature
1.••
Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, Kucuk O, Mailman J, Mao JJ. A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr 2017, 2017(52). ). (This paper is noteworthy as it provides a comprehensive, evidence-based, patient-centered operational definition of IO that was developed using rigorous methods. This is important for establishing consensus when describing, developing, and examining IO interventions.)
2.
Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract. 2019;35:33–47.PubMedCrossRef
3.
Qureshi M, Zelinski E, Carlson LE. Cancer and complementary therapies: current trends in survivors’ interest and use. Integr Cancer Ther. 2018;17(3):844–53.PubMedPubMedCentralCrossRef
4.
5.
6.
Carlson LE, Zelinski E, Toivonen K, Flynn M, Qureshi M, Piedalue KA, Grant R. Mind-body therapies in cancer: what is the latest evidence? Curr Oncol Rep. 2017;19(10):67.PubMedCrossRef
7.
Achterberg J. Imagery in healing: shamanism and modern medicine. Boston, New York: Random House; 2002.
8.
Roffe L, Schmidt K, Ernst E. A systematic review of guided imagery as an adjuvant cancer therapy. Psychooncology. 2005;14(8):607–17.PubMedCrossRef
9.
10.
Wallace KG. Analysis of recent literature concerning relaxation and imagery interventions for cancer pain. Cancer Nurs. 1997;20(2):79–87.PubMedCrossRef
11.••
Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194–232. (This clinical practice guideline contains a comprehensive overview of strength of the existing evidence base for multiple integrative therapies in breast cancer.)PubMedPubMedCentralCrossRef
12.
Tian X, Tang RY, Xu LL, Xie W, Chen H, Pi YP, Chen WQ. Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients: a systematic review of six randomized controlled trials. Support Care Cancer. 2020;28(9):4051–8.PubMedCrossRef
13.
Warth M, Zoller J, Kohler F, Aguilar-Raab C, Kessler J, Ditzen B. Psychosocial interventions for pain management in advanced cancer patients: a systematic review and meta-analysis. Curr Oncol Rep. 2020;22(1):3.PubMedPubMedCentralCrossRef
14.
Samuel SR, Gururaj R, Kumar KV, Vira P, Saxena PUP, Keogh JWL. Randomized control trial evidence for the benefits of massage and relaxation therapy on sleep in cancer survivors-a systematic review. J Cancer Surviv. 2021;15(5):799–810.PubMedCrossRef
15.••
GokMetin Z, Karadas C, Izgu N, Ozdemir L, Demirci U. Effects of progressive muscle relaxation and mindfulness meditation on fatigue, coping styles, and quality of life in early breast cancer patients: an assessor blinded, three-arm, randomized controlled trial. Eur J Oncol Nurs. 2019;42:116–25. (This 3-arm randomized controlled trial is noteworthy for its methodological rigor, including adequate power calculation, random allocation, outcome assessment completed by an independent researcher blinded to group membership, and use of an intent-to-treat analysis.)CrossRef
16.•
Mikolasek M, Witt CM, Barth J. Effects and implementation of a mindfulness and relaxation app for patients with cancer: mixed methods feasibility study. JMIR Cancer. 2021;7(1):e16785. (This mixed-methods feasibility study investigated a novel app for improving psychosocial symptoms; quantitative and qualitative results could both help inform app refinement and development.)PubMedPubMedCentralCrossRef
17.
Elkins GR, Barabasz AF, Council JR, Spiegel D. Advancing research and practice: the revised APA Division 30 definition of hypnosis. Int J Clin Exp Hypn. 2015;63(1):1–9.PubMedCrossRef
18.
Montgomery GH, Schnur JB, Kravits K. Hypnosis for cancer care: over 200 years young. CA Cancer J Clin. 2013;63(1):31–44.PubMedCrossRef
19.
Carlson LE, Toivonen K, Flynn M, Deleemans J, Piedalue KA, Tolsdorf E, Subnis U. The role of hypnosis in cancer care. Curr Oncol Rep. 2018;20(12):93.PubMedCrossRef
20.
Chen PY, Liu YM, Chen ML. The effect of hypnosis on anxiety in patients with cancer: a meta-analysis. Worldviews Evid Based Nurs. 2017;14(3):223–36.PubMedCrossRef
21.
Eitner S, Sokol B, Wichmann M, Bauer J, Engels D. Clinical use of a novel audio pillow with recorded hypnotherapy instructions and music for anxiolysis during dental implant surgery: a prospective study. Int J Clin Exp Hypn. 2011;59(2):180–97.PubMedCrossRef
22.
Montgomery GH, Hallquist MN, Schnur JB, David D, Silverstein JH, Bovbjerg DH. Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: response expectancies and emotional distress. J Consult Clin Psychol. 2010;78(1):80–8.PubMedPubMedCentralCrossRef
23.
Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024. https://​doi.​org/​10.​1200/​JCO.​22.​01357.CrossRefPubMed
24.•
Gregoire C, Faymonville ME, Vanhaudenhuyse A, Jerusalem G, Willems S, Bragard I. Randomized, controlled trial of an intervention combining self-care and self-hypnosis on fatigue, sleep, and emotional distress in posttreatment cancer patients: 1-year follow-up. Int J Clin Exp Hypn. 2022;70(2):136–55. (To date, this is the first study suggesting long-term effects at 1-year follow-up for a hypnosis intervention on fatigue, sleep, and distress after cancer treatment has been completed.)PubMedCrossRef
25.
Bragard I, Etienne AM, Faymonville ME, Coucke P, Lifrange E, Schroeder H, Wagener A, Dupuis G, Jerusalem G. A nonrandomized comparison study of self-hypnosis, yoga, and cognitive-behavioral therapy to reduce emotional distress in breast cancer patients. Int J Clin Exp Hypn. 2017;65(2):189–209.PubMed
26.
Gregoire C, Bragard I, Jerusalem G, Etienne AM, Coucke P, Dupuis G, Lanctot D, Faymonville ME. Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial. Br J Cancer. 2017;117(10):1442–9.PubMedPubMedCentralCrossRef
27.
Gregoire C, Nicolas H, Bragard I, Delevallez F, Merckaert I, Razavi D, Waltregny D, Faymonville ME, Vanhaudenhuyse A. Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients. BMC Cancer. 2018;18(1):677.PubMedPubMedCentralCrossRef
28.
Berliere M, Roelants F, Watremez C, Docquier MA, Piette N, Lamerant S, Megevand V, Van Maanen A, Piette P, Gerday A, et al. The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy. Breast. 2018;37:114–8.PubMedCrossRef
29.•
Moreno Hernandez D, Tellez A, Sanchez-Jauregui T, Garcia CH, Garcia-Solis M, Valdez A. Clinical hypnosis for pain reduction in breast cancer mastectomy: a randomized clinical trial. Int J Clin Exp Hypn. 2022;70(1):4–15. (Prior studies of hypnosis for pain management have largely relied on visual analog scales, whereas this study used a more in-depth pain inventory before, after, and 1-week post-surgery. Results suggest that clinical hypnosis was acceptable and can be integrated into postmastectomy pain management with beneficial effects on pain and improving quality of life in breast cancer patients.)PubMedCrossRef
30.
Amraoui J, Pouliquen C, Fraisse J, Dubourdieu J, Rey DitGuzer S, Leclerc G, de Forges H, Jarlier M, Gutowski M, Bleuse JP, et al. Effects of a hypnosis session before general anesthesia on postoperative outcomes in patients who underwent minor breast cancer surgery: the HYPNOSEIN Randomized Clinical Trial. JAMA Netw Open. 2018;1(4):e181164.PubMedPubMedCentralCrossRef
31.
Ospina MB, Bond K, Karkhaneh M, Buscemi N, Dryden DM, Barnes V, Carlson LE, Dusek JA, Shannahoff-Khalsa D. Clinical trials of meditation practices in health care: characteristics and quality. J Altern Complement Med. 2008;14(10):1199–213.PubMedCrossRef
32.
Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York, United States of America: Bantam Books; 2013.
33.
Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000;62(5):613–22.PubMedCrossRef
34.
35.
Zhang Q, Zhao H, Zheng Y. Effectiveness of mindfulness-based stress reduction (MBSR) on symptom variables and health-related quality of life in breast cancer patients-a systematic review and meta-analysis. Support Care Cancer. 2019;27(3):771–81.PubMedCrossRef
36.
Cillessen L, Johannsen M, Speckens AEM, Zachariae R. Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: a systematic review and meta-analysis of randomized controlled trials. Psychooncology. 2019;28(12):2257–69.PubMedPubMedCentralCrossRef
37.••
Pedro J, Monteiro-Reis S, Carvalho-Maia C, Henrique R, Jeronimo C, Silva ER. Evidence of psychological and biological effects of structured mindfulness-based interventions for cancer patients and survivors: a meta-review. Psychooncology. 2021;30(11):1836–48. (This paper is noteworthy because they did a meta-review, which is a meta-analysis of all the previous review papers in the area. This adds an extra layer of methodological rigor and summarizes the best clinical research in the area, bringing together a grand summary of overall outcomes. This is necessary due to the large number of meta-analyses and systematic reviews previously published.)PubMedPubMedCentralCrossRef
38.
39.
Park CL, Finkelstein-Fox L, Sacco SJ, Braun TD, Lazar S. How does yoga reduce stress? A clinical trial testing psychological mechanisms. Stress Health. 2021;37(1):116–26.PubMedCrossRef
40.
Gonzalez M, Pascoe MC, Yang G, de Manincor M, Grant S, Lacey J, Firth J, Sarris J. Yoga for depression and anxiety symptoms in people with cancer: a systematic review and meta-analysis. Psychooncology. 2021;30(8):1196–208.PubMedCrossRef
41.••
O’Neill M, Samaroo D, Lopez C, Tomlinson G, Santa Mina D, Sabiston C, Culos-Reed N, Alibhai SMH. The effect of yoga interventions on cancer-related fatigue and quality of life for women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Integr Cancer Ther. 2020;19:1534735420959882. (This recent meta-analysis included studies comparing yoga to active comparison groups. This comparative approach is of particular importance because it can provide guidance on whether yoga is superior to other potential therapies with regard to cost and effectiveness.)PubMedPubMedCentral
42.
Danhauer SC, Addington EL, Cohen L, Sohl SJ, Van Puymbroeck M, Albinati NK, Culos-Reed SN. Yoga for symptom management in oncology: a review of the evidence base and future directions for research. Cancer. 2019;125(12):1979–89.PubMedCrossRef
43.
Lin PJ, Kleckner IR, Loh KP, Inglis JE, Peppone LJ, Janelsins MC, Kamen CS, Heckler CE, Culakova E, Pigeon WR, et al. Influence of yoga on cancer-related fatigue and on mediational relationships between changes in sleep and cancer-related fatigue: a nationwide, multicenter randomized controlled trial of yoga in cancer survivors. Integr Cancer Ther. 2019;18:1534735419855134.PubMedPubMedCentralCrossRef
44.
Selvan P, Hriso C, Mitchell J, Newberg A. Systematic review of yoga for symptom management during conventional treatment of breast cancer patients. Complement Ther Clin Pract. 2022;48:101581.PubMedCrossRef
45.
Agarwal RP, Maroko-Afek A. Yoga into cancer care: a review of the evidence-based research. Int J Yoga. 2018;11(1):3–29.PubMedPubMedCentral
46.
Hsueh EJ, Loh EW, Lin JJ, Tam KW. Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials. Breast Cancer. 2021;28(2):264–76.PubMedCrossRef
47.
Baydoun M, Oberoi D, Flynn M, Moran C, McLennan A, Piedalue KL, Carlson LE. Effects of yoga-based interventions on cancer-associated cognitive decline: a systematic review. Curr Oncol Rep. 2020;22(10):100.PubMedCrossRef
48.
Huberty J, Eckert R, Dueck A, Kosiorek H, Larkey L, Gowin K, Mesa R. Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research. BMC Complement Altern Med. 2019;19(1):121.PubMedPubMedCentralCrossRef
49.•
Kaushik D, Shah PK, Mukherjee N, Ji N, Dursun F, Kumar AP, Thompson IM Jr, Mansour AM, Jha R, Yang X, et al. Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. Prostate Cancer Prostatic Dis. 2022;25(3):531–8. (While much of the research in this field included women with breast cancer, this study randomized men with prostate cancer to a hatha yoga program or standard care. The investigators demonstrated quality of life and immune response improvements in patients who received yoga.)PubMedCrossRef
50.
51.
52.
Zeng Y, Xie X, Cheng ASK. Qigong or Tai Chi in cancer care: an updated systematic review and meta-analysis. Curr Oncol Rep. 2019;21(6):48.PubMedCrossRef
53.
Wayne PM, Lee MS, Novakowski J, Osypiuk K, Ligibel J, Carlson LE, Song R. Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis. J Cancer Surviv. 2018;12(2):256–67.PubMedCrossRef
54.•
Yang L, Winters-Stone K, Rana B, Cao C, Carlson LE, Courneya KS, Friedenreich CM, Schmitz KH. Tai Chi for cancer survivors: a systematic review toward consensus-based guidelines. Cancer Med. 2021;10(21):7447–56. (This review is important as it synthesizes the current evidence on Tai Chi interventions in cancer survivors specifically and highlights key methodological challenges and areas for future research. These findings can support evidence-based practice guidelines.)PubMedPubMedCentralCrossRef
55.
Lopez G, Narayanan S, Christie A, Powers-James C, Liu W, Garcia MK, Gomez T, Wu J, Chunduru A, Williams JL, et al. Effects of center-based delivery of Tai Chi and Qi Gong group classes on self-reported symptoms in cancer patients and caregivers. Integr Cancer Ther. 2020;19:1534735420941605.PubMedPubMedCentralCrossRef
56.
Osypiuk K, Ligibel J, Giobbie-Hurder A, Vergara-Diaz G, Bonato P, Quinn R, Ng W, Wayne PM. Qigong mind-body exercise as a biopsychosocial therapy for persistent post-surgical pain in breast cancer: a pilot study. Integr Cancer Ther. 2020;19:1534735419893766.PubMedPubMedCentralCrossRef
57.
Karkou V, Sanderson P. Arts therapies: a research-based map of the field. London, United Kingdom: Elsevier Churchill Livingstone; 2006.CrossRef
58.
Boehm K, Cramer H, Staroszynski T, Ostermann T. Arts therapies for anxiety, depression, and quality of life in breast cancer patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2014;2014:103297.PubMedPubMedCentralCrossRef
59.
Puig A, Lee SM, Goodwin L, Sherrard PAD. The efficacy of creative arts therapies to enhance emotional expression, spirituality, and psychological well-being of newly diagnosed stage I and stage II breast cancer patients: a preliminary study. Arts Psychother. 2006;33(3):218–28.CrossRef
60.
61.••
Cheng P, Xu L, Zhang J, Liu W, Zhu J. Role of arts therapy in patients with breast and gynecological cancers: a systematic review and meta-analysis. J Palliat Med. 2021;24(3):443–52. https://​doi.​org/​10.​1089/​jpm.​2020.​0468. (This study is noteworthy for being a comprehensive meta-analysis of RCT trials on multiple types of popular art therapies (music, painting, dance), and Egger’s test detected no risk of publication bias for quality of life, anxiety, and depression outcomes.)
62.
Kievisiene J, Jautakyte R, Rauckiene-Michaelsson A, Fatkulina N, Agostinis-Sobrinho C, Xu Y, Yuan X. The effect of art therapy and music therapy on breast cancer patients: What we know and what we need to find out: a systematic review. Evid-Based Complement Altern Med. 2020;1–14.
63.
Bieligmeyer S, Helmert E, Hautzinger M, Vagedes J. Feeling the sound - short-term effect of a vibroacoustic music intervention on well-being and subjectively assessed warmth distribution in cancer patients-a randomized controlled trial. Complement Ther Med. 2018;40:171–8.PubMedCrossRef
64.
Gallagher LM, Lagman R, Rybicki L. Outcomes of music therapy interventions on symptom management in palliative medicine patients. Am J Hosp Palliat Care. 2018;35(2):250–7.PubMedCrossRef
65.
Ramirez R, Planas J, Escude N, Mercade J, Farriols C. EEG-based analysis of the emotional effect of music therapy on palliative care cancer patients. Front Psychol. 2018;9:254.PubMedPubMedCentralCrossRef
66.
Rossetti A, Chadha M, Torres BN, Lee JK, Hylton D, Loewy JV, Harrison LB. The impact of music therapy on anxiety in cancer patients undergoing simulation for radiation therapy. Int J Radiat Oncol Biol Phys. 2017;99(1):103–10.PubMedPubMedCentralCrossRef
67.
Gramaglia C, Gambaro E, Vecchi C, Licandro D, Raina G, Pisani C, Burgio V, Farruggio S, Rolla R, Deantonio L, et al. Outcomes of music therapy interventions in cancer patients-a review of the literature. Crit Rev Oncol Hematol. 2019;138:241–54.PubMedCrossRef
68.
69.
Czamanski-Cohen JP, Wiley JFP, Sela NB. Caspi O Md P, Weihs KM: The role of emotional processing in art therapy (REPAT) for breast cancer patients. J Psychosoc Oncol. 2019;37(5):586–98.PubMedCrossRef
70.•
Effa CJ, Dolgoy ND, McNeely ML. Resistance exercise and art therapy on body image in breast cancer: a scoping review. Womens Health Rep (New Rochelle). 2020;1(1):424–35. (This study is noteworthy for identifying preliminary evidence that resistance exercise in combination with art therapy may be effective at improving body image perceptions among breast cancer survivors, but that combining these therapies has yet to be studied. The authors provide clear direction on how theory and more rigorours methodology (e.g., defining body image) should be implemented when studying this emerging area of interest.)PubMed
71.
Hertrampf R-S, Wärja M. The effect of creative arts therapy and arts medicine on psychological outcomes in women with breast or gynecological cancer: a systematic review of arts-based interventions. Arts Psychother. 2017;63:53–110.
72.
Reilly RC, Lee V, Laux K, Robitaille A. Using found poetry to illuminate the existential and posttraumatic growth of women with breast cancer engaging in art therapy. Qual Res Psychol. 2018;15:196–217.CrossRef
73.•
74.
Rubik B, Muehsam D, Hammerschlag R, Jain S. Biofield science and healing: history, terminology, and concepts. Glob Adv Health Med. 2015;4(Suppl):8–14.PubMedPubMedCentral
75.
Jain S, Hammerschlag R, Mills P, Cohen L, Krieger R, Vieten C, Lutgendorf S. Clinical studies of biofield therapies: summary, methodological challenges, and recommendations. Glob Adv Health Med. 2015;4(Suppl):58–66.PubMedPubMedCentral
76.•
Yang P, Rhea PR, Conway T, Nookala S, Hegde V, Gagea M, Ajami NJ, Harribance SL, Ochoa J, Sastry JK, et al. Human biofield therapy modulates tumor microenvironment and cancer stemness in mouse lung carcinoma. Integr Cancer Ther. 2020;19:1534735420940398. (This paper is noteworthy as it provides some of the first evidence for potential mechanistic factors impacting tumor biology when a biofield therapy is applied. This may help improve the acceptance of biofield therapies within the biomedical community.)PubMedPubMedCentralCrossRef
77.
Yang P, Jiang Y, Rhea PR, Coway T, Chen D, Gagea M, Harribance SL, Cohen L. Human biofield therapy and the growth of mouse lung carcinoma. Integr Cancer Ther. 2019;18:1534735419840797.PubMedPubMedCentralCrossRef
78.
Tabatabaee A, Tafreshi MZ, Rassouli M, Aledavood SA, AlaviMajd H, Farahmand SK. Effect of therapeutic touch in patients with cancer: a literature review. Med Arch. 2016;70(2):142–7.PubMedPubMedCentralCrossRef
79.
Gonella S, Garrino L, Dimonte V. Biofield therapies and cancer-related symptoms: a review. Clin J Oncol Nurs. 2014;18(5):568–76.PubMedCrossRef
80.
Karaman S, Tan M. Effect of Reiki therapy on quality of life and fatigue levels of breast cancer patients receiving chemotherapy. Cancer Nurs. 2021;44(6):E652–8.PubMedCrossRef
81.
El-Seedi HR, De Smet PA, Beck O, Possnert G, Bruhn JG. Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. J Ethnopharmacol. 2005;101(1–3):238–42.PubMedCrossRef
82.
Rosa WE, Hope S, Matzo M. Palliative nursing and sacred medicine: a holistic stance on entheogens, healing, and spiritual care. J Holist Nurs. 2019;37(1):100–6.PubMedCrossRef
83.
Bonn-Miller MO, Bernstein A, Sachs-Ericsson N, Schmidt NB, Zvolensky MJ. Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample. J Anxiety Disord. 2007;21(5):730–41.PubMedCrossRef
84.
85.
86.
Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014;202(7):513–20.PubMedPubMedCentralCrossRef
87.•
Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponte KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol. 2020;34(2):155–66. (To date, this is the first report of long-term effects of psilocybin treatment in patients with cancer-related psychiatric and existential distress at two long-term follow-ups (i.e., 3.2 years and 4.5 years follow-up).)PubMedCrossRef
88.
Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181–97.PubMedPubMedCentralCrossRef
89.
Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, et al. Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer. ACS Pharmacol Transl Sci. 2021;4(2):553–62.PubMedPubMedCentralCrossRef
90.
Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30(12):1165–80.PubMedPubMedCentralCrossRef
91.
92.•
Fan W, Yang H, Sun Y, Zhang J, Li G, Zheng Y, Liu Y. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Oncotarget. 2017;8(2):2356–60. (Using a rigorous methodological design, this study provides novel evidence of ketamine-assisted therapy for the potential treatment of acutely developed depression and suicidal ideation in patients with newly diagnosed cancer.)PubMedCrossRef
93.
Liu P, Li P, Li Q, Yan H, Shi X, Liu C, Zhang Y, Peng S. Effect of pretreatment of s-ketamine on postoperative depression for breast cancer patients. J Invest Surg. 2021;34(8):883–8.PubMedCrossRef
94.
Ren Q, Hua L, Zhou X, Cheng Y, Lu M, Zhang C, Guo J, Xu H. Effects of a single sub-anesthetic dose of ketamine on postoperative emotional responses and inflammatory factors in colorectal cancer patients. Front Pharmacol. 2022;13:818822.PubMedPubMedCentralCrossRef
95.
Zhou Y, Sun W, Zhang G, Wang A, Lin S, Chan MTV, Peng Y, Wang G, Han R. Ketamine alleviates depressive symptoms in patients undergoing intracranial tumor resection: a randomized controlled trial. Anesth Analg. 2021;133(6):1588–97.PubMedCrossRef
96.
97.
Glasgow RE. What does it mean to be pragmatic? Pragmatic methods, measures, and models to facilitate research translation. Health Educ Behav. 2013;40(3):257–65.PubMedCrossRef
98.
Sacristan JA. Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients. BMC Med Inform Decis Mak. 2013;13:6.PubMedPubMedCentralCrossRef
99.
Odeh B, Kayyali R, Nabhani-Gebara S, Philip N. Optimizing cancer care through mobile health. Support Care Cancer. 2015;23(7):2183–8.PubMedCrossRef
100.
Klasnja P, Pratt W. Healthcare in the pocket: mapping the space of mobile-phone health interventions. J Biomed Inform. 2012;45(1):184–98.PubMedCrossRef
101.
Ellis LA, Collin P, Hurley PJ, Davenport TA, Burns JM, Hickie IB. Young men’s attitudes and behaviour in relation to mental health and technology: implications for the development of online mental health services. BMC Psychiatry. 2013;13:119.PubMedPubMedCentralCrossRef
102.
Heiniger LE, Smith AB, Olver I, Grimison P, Klein B, Wootten A, Abbott JM, Price MA, McJannett M, Tran B, Stockler MR, Gurney H, Butow PN. e-TC: development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. Eur J Cancer Care (Engl). 2017;26(6). https://​doi.​org/​10.​1111/​ecc.​12698.
103.
Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, et al. Feasibility, acceptability, and behavioral outcomes from a technology-enhanced behavioral change intervention (prostate 8): a pilot randomized controlled trial in men with prostate cancer. Eur Urol. 2019;75(6):950–8.PubMedCrossRef
Metadata
Title
Recent Progress in Mind–Body Therapies in Cancer Care
Authors
Julie M. Deleemans
Haley Mather
Athina Spiropoulos
Kirsti Toivonen
Mohamad Baydoun
Linda E. Carlson
Publication date
08-02-2023
Publisher
Springer US
Published in
Current Oncology Reports / Issue 4/2023
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-023-01373-w

Other articles of this Issue 4/2023

Current Oncology Reports 4/2023 Go to the issue

EVOLVING THERAPIES (RM BUKOWSKI, SECTION EDITOR)

Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates

ReviewPaper

Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review

BREAST CANCER (ME GATTI-MAYS, SECTION EDITOR)

Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis

ReviewPaper

Perioperative Anticoagulation in Patients with Cancer

HEAD AND NECK CANCERS (EY HANNA, SECTION EDITOR)

Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews

ReviewPaper

An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits